Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramCHIEF SCIENTIFIC OFFICERCIK 0001967150
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER |  ELVNEnliven Therapeutics, Inc.Grant or award | A | — 112.5K sh | Feb 17, 2026 traded Feb 12, 2026 | |
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER |
| ELVNEnliven Therapeutics, Inc. Grant or award |
| A |
| — 18.8K sh |
| Feb 17, 2026 traded Feb 12, 2026 |
| 1 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $145K 5,000 sh | Feb 10, 2026 traded Feb 6, 2026 |
| 6 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $145K 5,491 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 9 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $390K 14.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 9 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $151K 7,500 sh | Jan 12, 2026 traded Jan 8, 2026 |
| 19 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.46M 50.0K sh | Jan 12, 2026 traded Jan 9, 2026 |
| 12 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $842K 33.8K sh | Jan 12, 2026 traded Jan 8, 2026 |
| 15 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.03M 41.2K sh | Jan 12, 2026 traded Jan 9, 2026 |
| 9 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $84K 5,000 sh | Dec 23, 2025 traded Dec 19, 2025 |
| 15 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $11K 492 sh | Nov 21, 2025 traded Nov 19, 2025 |
| 21 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $268K 12.0K sh | Nov 21, 2025 traded Nov 19, 2025 |